Effect of Mild and Moderate Hepatic Impairment (defined by Child–Pugh Classification and National Cancer Institute Organ Dysfunction Working Group Criteria) on Pexidartinib Pharmacokinetics
The Journal of Clinical Pharmacology(2022)
Key words
Child-Pugh,hepatic impairment (HI),mild HI,moderate HI,NCI-ODWG,pexidartinib,pharmacokinetics,tenosynovial giant cell tumor (TGCT),ZAAD-1006A
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined